150 related articles for article (PubMed ID: 3816019)
1. Hydroxylation of desmethylimipramine: dependence on the debrisoquin hydroxylation phenotype.
Spina E; Steiner E; Ericsson O; Sjöqvist F
Clin Pharmacol Ther; 1987 Mar; 41(3):314-9. PubMed ID: 3816019
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
Spina E; Birgersson C; von Bahr C; Ericsson O; Mellström B; Steiner E; Sjöqvist F
Clin Pharmacol Ther; 1984 Nov; 36(5):677-82. PubMed ID: 6488689
[TBL] [Abstract][Full Text] [Related]
3. Differences in the inhibitory effect of cimetidine on desipramine metabolism between rapid and slow debrisoquin hydroxylators.
Steiner E; Spina E
Clin Pharmacol Ther; 1987 Sep; 42(3):278-82. PubMed ID: 3621781
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of desipramine 2-hydroxylation by quinidine and quinine in rapid and slow debrisoquine hydroxylators.
Spina E; Steiner E; Dumont E; Dahlqvist R
Psychopharmacol Ser; 1989; 7():201-5. PubMed ID: 2687858
[No Abstract] [Full Text] [Related]
5. E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
Mellström B; Bertilsson L; Säwe J; Schulz HU; Sjöqvist F
Clin Pharmacol Ther; 1981 Aug; 30(2):189-93. PubMed ID: 7249504
[TBL] [Abstract][Full Text] [Related]
6. Relationship between uptake and elimination of toluene and debrisoquin hydroxylation polymorphism.
Löf A; Hansen SH; Näslund P; Steiner E; Wallén M; Hjelm EW
Clin Pharmacol Ther; 1990 Mar; 47(3):412-7. PubMed ID: 2311341
[TBL] [Abstract][Full Text] [Related]
7. Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype.
Bertilsson L; Henthorn TK; Sanz E; Tybring G; Säwe J; Villén T
Clin Pharmacol Ther; 1989 Apr; 45(4):348-55. PubMed ID: 2495208
[TBL] [Abstract][Full Text] [Related]
8. Interethnic dissociation between debrisoquine and desipramine hydroxylation.
Rudorfer MV; Lane EA; Potter WZ
J Clin Psychopharmacol; 1985 Apr; 5(2):89-92. PubMed ID: 3988975
[TBL] [Abstract][Full Text] [Related]
9. The debrisoquin hydroxylation phenotype does not predict the metabolism of phenytoin.
Steiner E; Alván G; Garle M; Maguire JH; Lind M; Nilson SO; Tomson T; McClanahan JS; Sjöqvist F
Clin Pharmacol Ther; 1987 Sep; 42(3):326-33. PubMed ID: 3621788
[TBL] [Abstract][Full Text] [Related]
10. Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human beings.
Dahl-Puustinen ML; Lidén A; Alm C; Nordin C; Bertilsson L
Clin Pharmacol Ther; 1989 Jul; 46(1):78-81. PubMed ID: 2743709
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic debrisoquin hydroxylation in 757 Swedish subjects.
Steiner E; Bertilsson L; Säwe J; Bertling I; Sjöqvist F
Clin Pharmacol Ther; 1988 Oct; 44(4):431-5. PubMed ID: 3168394
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype.
von Bahr C; Movin G; Nordin C; Lidén A; Hammarlund-Udenaes M; Hedberg A; Ring H; Sjöqvist F
Clin Pharmacol Ther; 1991 Mar; 49(3):234-40. PubMed ID: 2007317
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of desipramine 2-hydroxylation by quinidine and quinine.
Steiner E; Dumont E; Spina E; Dahlqvist R
Clin Pharmacol Ther; 1988 May; 43(5):577-81. PubMed ID: 3365919
[TBL] [Abstract][Full Text] [Related]
14. Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.
Woolhouse NM; Adjepon-Yamoah KK; Mellström B; Hedman A; Bertilsson L; Sjöqvist F
Clin Pharmacol Ther; 1984 Sep; 36(3):374-8. PubMed ID: 6467797
[TBL] [Abstract][Full Text] [Related]
15. Desmethylimipramine overdose: nonlinear kinetics in a slow hydroxylator.
Spina E; Henthorn TK; Eleborg L; Nordin C; Säwe J
Ther Drug Monit; 1985; 7(2):239-41. PubMed ID: 4024220
[TBL] [Abstract][Full Text] [Related]
16. A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin.
Steiner E; Iselius L; Alván G; Lindsten J; Sjöqvist F
Clin Pharmacol Ther; 1985 Oct; 38(4):394-401. PubMed ID: 4042522
[TBL] [Abstract][Full Text] [Related]
17. Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.
Yue QY; Svensson JO; Alm C; Sjöqvist F; Säwe J
Br J Clin Pharmacol; 1989 Dec; 28(6):639-45. PubMed ID: 2611086
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population.
Dahl ML; Johansson I; Palmertz MP; Ingelman-Sundberg M; Sjöqvist F
Clin Pharmacol Ther; 1992 Jan; 51(1):12-7. PubMed ID: 1346258
[TBL] [Abstract][Full Text] [Related]
19. Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.
Sjöqvist F; Bertilsson L
Prog Clin Biol Res; 1986; 214():169-88. PubMed ID: 3523507
[TBL] [Abstract][Full Text] [Related]
20. Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.
Lennard MS; Silas JH; Freestone S; Trevethick J
Br J Clin Pharmacol; 1982 Aug; 14(2):301-3. PubMed ID: 6125207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
